4D Molecular Therapeutics, Inc 10-Q for FY2022 Q3
4D Molecular Therapeutics, Inc. (FDMT)
10-Q
2022-11-08
For: 2022-09-30
View Original
Added on
April 08, 2026
About this 10-Q
4D Molecular Therapeutics, Inc filed this 10-Q on November 8, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $500K
- down 63.4% from $1.37M a year earlier
- Net loss
- $25.69M
- compared with a net loss of $22.24M a year earlier
- Diluted EPS
- -$0.79
- compared with -$0.82 a year earlier